Autoinflammatory syndromes for the dermatologist

Clinics in Dermatology

Volumn 32, Issue 4, 2014, Pages 488-501

  Dávila Seijo, Paula ^a   Hernández Martín, Angela ^a   Torrelo, Antonio ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CANAKINUMAB; CIMETIDINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; ERYTHROMYCIN; ETANERCEPT; IMMUNOGLOBULIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; SALAZOSULFAPYRIDINE; THALIDOMIDE;

AUTOINFLAMMATORY DISEASE; BLAU SYNDROME; CHILD; CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CINCA SYNDROME; CLINICAL FEATURE; DEFICIENCY OF INTERLEUKIN 36 RECEPTOR ANTAGONIST SYNDROME; DEFICIENCY OF THE INTERLEUKIN 1 RECEPTOR ANTAGONIST SYNDROME; DERMATOLOGIST; DISEASE EXACERBATION; DRUG CHOICE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; DRUG SAFETY; ERYSIPELOID; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HEARING IMPAIRMENT; HEREDITARY PERIODIC FEVER; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; INNATE IMMUNITY; LABORATORY TEST; MAJEED SYNDROME; MOLECULAR PATHOLOGY; MUCKLE WELLS SYNDROME; NOTE; OUTCOME ASSESSMENT; PAPA SYNDROME; PARADOXICAL DRUG REACTION; PFAPA SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; SKIN DEFECT; SKIN MANIFESTATION; SKIN ULCER; TONSILLECTOMY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; UNSPECIFIED SIDE EFFECT; AUTOIMMUNE DISEASES; AUTOIMMUNITY; COMPLICATION; DERMATOLOGY; HEALTH STATUS; HEREDITARY AUTOINFLAMMATORY DISEASES; IMMUNOLOGY; INFLAMMATION; SKIN DISEASES; STANDARDS;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHILD; DERMATOLOGY; HEALTH STATUS; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; SKIN DISEASES;

EID: 84903983473     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2014.02.004     Document Type: Note

References (111)

1. Nigrovic P.A. Periodic fever syndromes and other autoinflammatory diseases: an overview 2012, [UpToDate®].
2. Lachmann H.J., Quartier P., So A., Hawkins P.N. The emerging role of interleukin-1 beta in autoinflammatory diseases. Arthritis Rheum 2011, 63:314-324.
3. Heymann W.R. The interplay of innate immunity, adaptive immunity, and autoimmunity. J Am Acad Dermatol 2007, 57:700-701.
4. Ben-Chetrit E., Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum 2009, 61:1447-1453.
5. Farasat S., Aksentijevich I., Toro J.R. Autoinflammatory diseases: clinical and genetic advances. Arch Dermatol 2008, 144:392-402.
6. The International FMF Consortium Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997, 90:797-807.
7. French FMF Consortium A candidate gene for familial Mediterranean fever. Nat Genet 1997, 17:25-31.
8. Shinkai K., Kilcline C., Connolly M.K., Frieden I.J. The pyrin family of fever genes: unmasking genetic determinants of autoinflammatory disease. Arch Dermatol 2005, 141:242-247.
9. Peter M., Rosenberg S.E.G. Pathophysiology of familial Mediterranean fever. © 2013 2012, [UpToDate].
10. Grateau G. The relation between familial Mediterranean fever and amyloidosis. Curr Opin Rheumatol 2000, 12:61-64.
11. Shinar Y., Livneh A., Langevitz P., et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000, 27:1703-1707.
12. Kone Paut I., Dubuc M., Sportouch J., Minodier P., Garnier J.M., Touitou I. Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology (Oxford) 2000, 39:1275-1279.
13. Marek-Yagel D., Berkun Y., Padeh S., et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 2009, 60:1862-1866.
14. Booty M.G., Chae J.J., Masters S.L., et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit?. Arthritis Rheum 2009, 60:1851-1861.
15. Pras M. Amyloidosis of familial mediterranean fever and the MEFV gene. Amyloid 2000, 7:289-293.
16. Touitou I., Picot M.C., Domingo C., et al. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 2001, 44:163-169.
17. Matzner Y., Partridge R.E., Levy M., Babior B.M. Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever. Blood 1984, 63:629-633.
18. Matzner Y., Brzezinski A. C5 a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med 1984, 311:287-290.
19. Peter M., Rosenberg S.E.G. Clinical manifestations and diagnosis of familial Mediterranean fever. © 2013 2011, [UpToDate].
20. Kees S., Langevitz P., Zemer D., Padeh S., Pras M., Livneh A. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). Q J Med 1997, 90:643-647.
21. Sohar E., Gafni J., Pras M., Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967, 43:227-253.
22. Majeed H.A., Quabazard Z., Hijazi Z., Farwana S., Harshani F. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study. Q J Med 1990, 75:607-616.
23. Gedalia A., Adar A., Gorodischer R. Familial Mediterranean fever in children. J Rheumatol Suppl 1992, 35:1-9.
24. Rawashdeh M.O., Majeed H.A. Familial mediterranean fever in Arab children: the high prevalence and gene frequency. Eur J Pediatr 1996, 155:540-544.
25. Barzilai A., Langevitz P., Goldberg I., et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 2000, 42:791-795.
26. Ozen S., Ben-Chetrit E., Bakkaloglu A., et al. Polyarteritis nodosa in patients with familial Mediterranean fever (FMF): a concomitant disease or a feature of FMF?. Semin Arthritis Rheum 2001, 30:281-287.
27. Ozdogan H., Arisoy N., Kasapcapur O., et al. Vasculitis in familial Mediterranean fever. J Rheumatol 1997, 24:323-327.
28. Bosacki C., Richard O., Freycon F., Mosnier J.F., Cathebras P. The association of polyarteritis nodosa and familial Mediterranean fever. Presse Med 2003, 32:24-26.
29. Tinaztepe K., Gucer S., Bakkaloglu A., Tinaztepe B. Familial Mediterranean fever and polyarteritis nodosa: experience of five paediatric cases. A causal relationship or coincidence?. Eur J Pediatr 1997, 156:505-506.
30. Peter M., Rosenberg S.E.G. Management of familial Mediterranean fever. © 2013 2010, [UpToDate].
31. Seyahi E., Ozdogan H., Celik S., Ugurlu S., Yazici H. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol 2006, 24:S99-S103.
32. Calligaris L., Marchetti F., Tommasini A., Ventura A. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr 2008, 167:695-696.
33. Hull K.M., Drewe E., Aksentijevich I., et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 2002, 81:349-368.
34. Toro J.R., Aksentijevich I., Hull K., Dean J., Kastner D.L. Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 2000, 136:1487-1494.
35. McDermott M.F., Ogunkolade B.W., McDermott E.M., et al. Linkage of familial Hibernian fever to chromosome 12 p13. Am J Hum Genet 1998, 62:1446-1451.
36. Mulley J., Saar K., Hewitt G., et al. Gene localization for an autosomal dominant familial periodic fever to 12 p13. Am J Hum Genet 1998, 62:884-889.
37. Kallinich T., Haffner D., Rudolph B., et al. "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1 A gene presenting with episodes of inflammation or monosymptomatic amyloidosis. Ann Rheum Dis 2006, 65:958-960.
38. Kallinich T., Briese S., Roesler J., et al. Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50 M) in the TNFRSF1 A gene associated with severe multiorganic amyloidosis. J Rheumatol 2004, 31:2519-2522.
39. Kanazawa N., Furukawa F. Autoinflammatory syndromes with a dermatological perspective. J Dermatol 2007, 34:601-608.
40. Nigrovic P.A. Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS). © 2013 2012, [UpToDate].
41. Grose C., Renee Schnetzer J., Ferrante A., Vladutiu A.O. Children with hyperimmunoglobulinemia D and periodic fever syndrome. Pediatr Infect Dis J 1996, 15:72-77.
42. Drenth J.P.H., Haagsma C.J., Van der Meer J.W.M., et al. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. Medicine 1994, 73:133-144.
43. Simon A., Cuisset L., Vincent M.F., et al. Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med 2001, 135:338-343.
44. Houten S.M., Koster J., Romeijn G.J., et al. Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome. Eur J Hum Genet 2001, 9:253-259.
45. Houten S.M., van Woerden C.S., Wijburg F.A., Wanders R.J., Waterham H.R. Carrier frequency of the V377 I (1129 G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet 2003, 11:196-200.
46. Drenth J.P., Cuisset L., Grateau G., et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 1999, 22:178-181.
47. Houten S.M., Frenkel J., Rijkers G.T., Wanders R.J., Kuis W., Waterham H.R. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 2002, 11:3115-3124.
48. Drenth J.P., Haagsma C.J., van der Meer J.W. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 1994, 73:133-144.
49. Yoram C., Padeh A.R. Hyperimmunoglobulin-D syndrome: pathophysiology. © 2013 2012, [UpToDate].
50. Armbrust S., Drenth J.P., Schroder C., Domning E., Poeschl E., Wiersbitzky S.K. Tendonitis in variant hyperimmunoglobulinaemia D and periodic fever syndrome-a rare disease with a new symptom. Eur J Pediatr 2005, 164:391-394.
51. Kraus C.L., Culican S.M. Nummular keratopathy in a patient with Hyper-IgD Syndrome. Pediatr Rheumatol Online J 2009, 7:14.
52. van der Hilst J.C., Simon A., Drenth J.P. Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 2005, 5:87-98.
53. Di Rocco M., Caruso U., Waterham H.R., Picco P., Loy A., Wanders R.J. Mevalonate kinase deficiency in a child with periodic fever and without hyperimmunoglobulinaemia D. J Inherit Metab Dis 2001, 24:411-412.
54. Drenth J.P., Boom B.W., Toonstra J., Van der Meer J.W. Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group. Arch Dermatol 1994, 130:59-65.
55. Yoram C., Padeh A.R. Hyperimmunoglobulin-D syndrome: management. © 2013 2012, [UpToDate].
56. Valenzuela P.M., Majerson D., Tapia J.L., Talesnik E. Syndrome of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) in siblings. Clin Rheumatol 2009, 28:1235-1237.
57. Padeh S., Brezniak N., Zemer D., et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 1999, 135:98-101.
58. Thomas K.T., Feder H.M., Lawton A.R., Edwards K.M. Periodic fever syndrome in children. J Pediatr 1999, 135:15-21.
59. Stojanov S., Hoffmann F., Kery A., et al. Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw 2006, 17:90-97.
60. Padeh S. Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome). © 2013 2012, [UpToDate].
61. Berkun Y., Levy R., Hurwitz A., et al. The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome. Semin Arthritis Rheum 2011, 40:467-472.
62. Neven B., Callebaut I., Prieur A.M., et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004, 103:2809-2815.
63. Neven B., Prieur A.M., Quartier dit Maire P. Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol 2008, 4:481-489.
64. Eisenbarth S.C., Colegio O.R., O'Connor W., Sutterwala F.S., Flavell R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
65. Aksentijevich I., C DP, Remmers E.F., Mueller J.L., et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 2007, 56:1273-1285.
66. Hoffman H.M., Wanderer A.A., Broide D.H. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 2001, 108:615-620.
67. Doeglas H.M., Bleumink E. Familial cold urticaria. Clinical findings. Arch Dermatol 1974, 110:382-388.
68. Peroni A., Colato C., Zanoni G., Girolomoni G. Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: Part II. Systemic diseases. J Am Acad Dermatol 2010, 62:557-570. [quiz 71-72].
69. Muckle T.J., Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 1962, 31:235-248.
70. Aganna E., Martinon F., Hawkins P.N., et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 2002, 46:2445-2452.
71. Muckle T.J. The 'Muckle-Wells' syndrome. Br J Dermatol 1979, 100:87-92.
72. Aksentijevich I., Nowak M., Mallah M., et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002, 46:3340-3348.
73. Goldfinger S. The inherited autoinflammatory syndrome: a decade of discovery. Trans Am Clin Climatol Assoc 2009, 120:413-418.
74. Ahmadi N., Brewer C.C., Zalewski C., et al. Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations. Otolaryngol Head Neck Surg 2011, 145:295-302.
75. Prieur A.M. A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol 2001, 19:103-106.
76. Goldbach-Mansky R., Dailey N.J., Canna S.W., et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1(beta) inhibition. N Engl J Med 2006, 355:581-592.
77. Huttenlocher A., Frieden I.J., Emery H. Neonatal onset multisystem inflammatory disease. J Rheumatol 1995, 22:1171-1173.
78. Nigrovic P.A. Cryopyrin-associated periodic syndromes and related disorders. © 2013 2012, [UpToDate].
79. Minkis K., Aksentijevich I., Goldbach-Mansky R., et al. Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis. Arch Dermatol 2012, 148:747-752.
80. Brau-Javier C.N., Gonzales-Chavez J., Toro J.R. Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2 q13: excellent response to anakinra. Arch Dermatol 2012, 148:301-304.
81. Reddy S., Jia S., Geoffrey R., et al. An autoinflammatory disease due to homozygous deletion of the IL1 RN locus. N Engl J Med 2009, 360:2438-2444.
82. Aksentijevich I., Masters S.L., Ferguson P.J., et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009, 360:2426-2437.
83. Altiok E., Aksoy F., Perk Y., et al. A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset. Clin Immunol 2012, 145:77-81.
84. Jesus A.A., Osman M., Silva C.A., et al. A novel mutation of IL1 RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Arthritis Rheum 2011, 63:4007-4017.
85. Onoufriadis A., Simpson M.A., Pink A.E., et al. Mutations in IL36 RN/IL1 F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet 2011, 89:432-437.
86. Marrakchi S., Guigue P., Renshaw B.R., et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011, 365:620-628.
87. Cowen E.W., Goldbach-Mansky R. DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?. Arch Dermatol 2012, 148:381-384.
88. Viguier M., Guigue P., Pages C., Smahi A., Bachelez H. Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1 RN mutations. Ann Intern Med 2010, 153:66-67.
89. Lindor N.M., Arsenault T.M., Solomon H., Seidman C.E., McEvoy M.T. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 1997, 72:611-615.
90. Yeon H.B., Lindor N.M., Seidman J.G., Seidman C.E. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15 q. Am J Hum Genet 2000, 66:1443-1448.
91. Hong J.B., Su Y.N., Chiu H.C. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2 BP1 gene. J Am Acad Dermatol 2009, 61:533-535.
92. Demidowich A.P., Freeman A.F., Kuhns D.B., et al. Genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum 2012, 64:2022-2027.
93. Demidowich A.P., Freeman A.F., Kuhns D.B., et al. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum 2012, 64:2022-2027.
94. Ter Haar N., Lachmann H., Ozen S., et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 2012, 72:678-685.
95. Miceli-Richard C., Lesage S., Rybojad M., et al. CARD15 mutations in Blau syndrome. Nat Genet 2001, 29:19-20.
96. Kanazawa N., Okafuji I., Kambe N., et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-(kappa)B activation: common genetic etiology with Blau syndrome. Blood 2005, 105:1195-1197.
97. Rose C.D., Doyle T.M., McIlvain-Simpson G., et al. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 2005, 32:373-375.
98. Rose C.D., Arostegui J.I., Martin T.M., et al. NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain. Arthritis Rheum 2009, 60:1797-1803.
99. Rose C.D., Wouters C.H., Meiorin S., et al. Pediatric granulomatous arthritis: an international registry. Arthritis Rheum 2006, 54:3337-3344.
100. Kambe N., Nishikomori R., Kanazawa N. The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders. J Dermatol Sci 2005, 39:71-80.
101. Blau E.B. Familial granulomatous arthritis, iritis, and rash. J Pediatr 1985, 107:689-693.
102. Manouvrier-Hanu S., Puech B., Piette F., et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature. Am J Med Genet 1998, 76:217-221.
103. Arostegui J.I., Arnal C., Merino R., et al. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 2007, 56:3805-3813.
104. Majeed H.A., El-Shanti H., Al-Rimawi H., Al-Masri N. On mice and men: an autosomal recessive syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia. J Pediatr 2000, 137:441-442.
105. Majeed H.A., Al-Tarawna M., El-Shanti H., Kamel B., Al-Khalaileh F. The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review. Eur J Pediatr 2001, 160:705-710.
106. Ferguson P.J., Chen S., Tayeh M.K., et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 2005, 42:551-557.
107. Herlin T., Fiirgaard B., Bjerre M., et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis 2012, 72:410-413.
108. Al-Mosawi Z.S., Al-Saad K.K., Ijadi-Maghsoodi R., El-Shanti H.I., Ferguson P.J. A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis Rheum 2007, 56:960-964.
109. El-Shanti H., Ferguson P. Majeed Syndrome. GeneReviews® [Internet] 1993-2014, University of Washington, Seattle, Seattle (WA), 2008 Sep 23 [updated 2013 Mar 14]. R.A. Pagon, M.P. Adam, H.H. Ardinger, T.D. Bird, C.R. Dolan, C.T. Fong, R.J.H. Smith, K. Stephens (Eds.).
110. Torrelo A., Patel S., Colmenero I., et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol 2010, 62:489-495.
111. Liu Y., Ramot Y., Torrelo A., et al. Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 2012, 64:895-907.